Patient explainer · Learn
The Emerging Field of Epigenetics
Uncovering Mechanisms of Heritable Gene Expression
This is a detailed subject, and what it means for your situation depends on your history. Dr. Glowney is glad to work through it with you.
How epigenetic regulation works.
Epigenetics, a field of growing scientific interest, examines the mechanisms by which genetic information is regulated without altering the underlying DNA sequence. This concept, introduced by Conrad Waddington in the 1940s, has evolved to encompass diverse epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNA regulation, which collectively shape the epigenome and influence gene expression patterns.
DNA methylation, one of the most well-characterized epigenetic mechanisms, involves adding a methyl group to the cytosine base within the DNA sequence, typically at CpG islands. This process can lead to gene silencing, as methylation can block the binding of transcription factors to DNA (Moore et al., 2013) (Liyanage et al., 2014). Conversely, hypomethylation can result in inappropriate gene activation, contributing to cancer (Van Tongelen et al., 2017).
Histone modifications, such as acetylation, methylation, phosphorylation, and ubiquitination, also play an important role in regulating gene expression. These chemical alterations to histone proteins can influence the structural configuration of chromatin, the complex of DNA and protein within the nucleus. Deacetylation of histones, for instance, regulates chromatin structure and transcription (Seto & Yoshida, 2014).
In addition to these well-studied mechanisms, non-coding RNAs, including microRNAs and long non-coding RNAs, have emerged as important participants in epigenetic regulation. These molecules can regulate gene expression by targeting messenger RNA (mRNA) or interacting with chromatin to modulate transcription (Leite et al., 2020) (Statello et al., 2021) (Zhao & Liu, 2009).
Epigenetics in development and disease.
Epigenetics has gained significant prominence in recent years, with advancements in molecular biology and the discovery of specific epigenetic mechanisms. These findings show how genes and their environment interact, with implications for disease (Handel et al., 2010).
Epigenetic mechanisms have implications in various fields, from developmental biology to human health and disease. As research in this field continues to evolve, the potential to harness these epigenetic mechanisms for therapeutic interventions and personalized medicine holds great promise (Leite et al., 2020) (Moosavi & Motevalizadeh Ardekani, 2016).
Epigenetics's importance extends beyond its foundational role in development and cellular differentiation. Epigenetic dysregulation has been implicated in a wide range of diseases, including cancer, neurological disorders, and metabolic conditions. Understanding these disease processes' epigenetic mechanisms can provide insights for developing targeted therapies and advancing precision medicine.
Open debates and research tools.
Despite the significant progress made in the field, scientists continue to debate and discuss the precise mechanisms by which epigenetic modifications influence gene expression. Some scientists argue that the histone marks and DNA modifications are important for changes in transcription. In contrast, others suggest that these modifications may be mere passengers rather than the driving force behind transcriptional regulation.
Gene-specific manipulation of chromatin has emerged as a powerful tool to further elucidate these complex mechanisms. This tool enables researchers to explore the causal relationships between epigenetic modifications and transcriptional outcomes.
Epigenetics has changed our understanding of gene expression and the role of heritable changes in shaping biological processes. From the fundamental mechanisms of DNA methylation and histone modifications to the emerging significance of non-coding RNAs, epigenetics has become a central focus in biomedical research. As this field continues to evolve, its potential to unlock new frontiers in precision medicine, disease treatment, and developmental biology remains immense (Chen et al., 2017).
Epigenetic therapies and precision medicine.
The emerging field of epigenetics has also shown promise in studying and treating infectious diseases (Zhou et al., 2018). By understanding the epigenetic mechanisms that contribute to the pathogenesis and progression of infectious diseases, researchers can explore novel therapeutic approaches that target these epigenetic regulators, opening up new avenues for disease management.
Furthermore, the concept of "epidrug repurposing" has gained traction, where researchers are discovering new applications for known chemical entities that may enhance epigenetic therapy in cancer and other diseases (Montalvo-Casimiro et al., 2020). This approach represents an exciting opportunity to accelerate the development of precision medicine by leveraging our existing knowledge of epigenetic mechanisms and drug properties.
As epigenetics continues to evolve, the integration of new biotechnological tools and computational approaches will be important in unraveling the complexity of the epigenome and its influence on biological processes. The future of epigenetics holds great promise for our understanding of human health and disease, and for the development of innovative, personalized therapeutic strategies.
Advancements in DNA sequencing and next-generation sequencing techniques have enabled the accumulation of large amounts of data, which have been instrumental in expanding our understanding of the molecular mechanisms associated with various diseases (Leite et al., 2020).
These technological advancements, combined with the growing body of research on epigenetic mechanisms, have paved the way for the emergence of precision medicine, in which patients' genetic and epigenetic profiles are leveraged for personalized diagnostics and treatments.
The continued evolution of epigenetics will undoubtedly lead to groundbreaking discoveries and innovative therapeutic strategies. Integrating bioengineering approaches with epigenetics research will be important in translating scientific knowledge into clinical applications as the field progresses.
Epigenetics has advanced our understanding of gene expression and biological processes and opened up new avenues for developing precision medicine (Leite et al., 2020).
Current limitations.
While epigenetics has made significant strides, challenges and limitations must be addressed. Specifically, the ability to precisely manipulate the epigenome remains limited, hindering our ability to generate detailed mechanistic insights and develop epigenetically targeted therapeutics (Day, 2014).
To overcome these challenges, researchers are developing new tools and approaches that enable controlled epigenetic editing at specific genes and cell types. These advancements hold the potential to unlock the full promise of epigenetic therapies and accelerate the translation of epigenetic research into clinical applications.
References
Sources cited.
- Chen, Z., Li, S., Subramaniam, S., Shyy, J. Y., & Chien, S. (2017). Epigenetic Regulation: A New Frontier for Biomedical Engineers. Annual Review of Biomedical Engineering, 19, 195–219. https://doi.org/10.1146/annurev-bioeng-071516-044720
- Day, J. J. (2014). New approaches to manipulating the epigenome. Dialogues in Clinical Neuroscience, 16(3), 345–357. https://doi.org/10.31887/DCNS.2014.16.3/jday
- Handel, A. E., Ebers, G. C., & Ramagopalan, S. V. (2010). Epigenetics: molecular mechanisms and implications for disease. Trends in Molecular Medicine, 16(1), 7–16. https://doi.org/10.1016/j.molmed.2009.11.003
- Leite, M. L., de Oliveira, K. B. S., Cunha, V. A., Dias, S. C., da Cunha, N. B., & Costa, F. F. (2020). Epigenetic therapies in the precision medicine era. Advanced Therapeutics, 3(8), 1900184. https://doi.org/10.1002/adtp.201900184
- Liyanage, V. R., Jarmasz, J. S., Murugeshan, N., Del Bigio, M. R., Rastegar, M., & Davie, J. R. (2014). DNA modifications: function and applications in normal and disease states. Biology, 3(4), 670–723. https://doi.org/10.3390/biology3040670
- Montalvo-Casimiro, M., González-Barrios, R., Meraz-Rodriguez, M. A., Juárez-González, V. T., Arriaga-Canon, C., & Herrera, L. A. (2020). Epidrug repurposing: Discovering new faces of old acquaintances in cancer therapy. Frontiers in Oncology, 10, 605386. https://doi.org/10.3389/fonc.2020.605386
- Moore, L. D., Le, T., & Fan, G. (2013). DNA methylation and its basic function. Neuropsychopharmacology, 38(1), 23–38. https://doi.org/10.1038/npp.2012.112
- Moosavi, A., & Motevalizadeh Ardekani, A. (2016). Role of Epigenetics in Biology and Human Diseases. Iranian Biomedical Journal, 20(5), 246–258. https://doi.org/10.22045/ibj.2016.01
- Seto, E., & Yoshida, M. (2014). Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harbor Perspectives in Biology, 6(4), a018713. https://doi.org/10.1101/cshperspect.a018713
- Statello, L., Guo, C. J., Chen, L. L., & Huarte, M. (2021). Gene regulation by long non-coding RNAs and its biological functions. Nature Reviews Molecular Cell Biology, 22(2), 96–118. https://doi.org/10.1038/s41580-020-00315-9
- Van Tongelen, A., Loriot, A., & De Smet, C. (2017). Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. Cancer Letters, 396, 130–137. https://doi.org/10.1016/j.canlet.2017.03.029
- Zhao, S., & Liu, M. F. (2009). Mechanisms of microRNA-mediated gene regulation. Science in China Series C: Life Sciences, 52(12), 1111–1116. https://doi.org/10.1007/s11427-009-0152-y
- Zhou, Z., Rajasingh, S., Barani, B., Samanta, S., Dawn, B., Wang, R., & Rajasingh, J. (2018). Therapy of infectious diseases using epigenetic approaches. In Epigenetics in Human Disease (pp. 689–715). Elsevier. https://doi.org/10.1016/b978-0-12-812215-0.00022-4
Related patient explainers